0 items USD 0.00Search
Your search for "prof research 2016 global chinese apatinib mesylate industry market research report" gave back 1521283 results.
It is an alpha1 adrenergic antagonist indicated for:Signs and symptoms of Benign Prostatic Hyperplasia (BPH),Treatment of Hypertension. The global...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Gabexate Mesylate for Injection market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Bromocriptine, an ergoline derivative, is a dopamine agonist that is used in the treatment of pituitary tumors, Parkinson’s disease (PD),...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Leucomethylene blue (TRx0237) mesylate, an orally active second-generation tau protein aggregation inhibitor (Ki of 0.12 μM), could be used for the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Pharmaceutical Grade Safinamide Mesylate market was valued at US$ 510 million in 2022 and is anticipated to reach US$ 652.8 million by...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Imatinib Mesylate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Pharmaceutical Grade Eribulin Mesylate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Rasagiline Mesylate API market will undergo major changes...
Catalog:
Arsta
September 2022
Price: USD 3,360.00
It is an alpha1 adrenergic antagonist indicated for:Signs and symptoms of Benign Prostatic Hyperplasia (BPH),Treatment of Hypertension. The global...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Rasagiline Mesylate Tablets (Azilect) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Imatinib is a medication used to treat cancer. The global Imatinib Mesylate Drugs market is projected to grow from US$ million in 2023 to US$ million...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global Paroxetine Mesylate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Imatinib Mesylate Tablets Market The global Imatinib Mesylate Tablets market is projected to grow from US$...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Imatinib Mesylate market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global Naltriben Mesylate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of...
Catalog:
LPI
April 2023
Price: USD 3,660.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
